Literature DB >> 15976333

Human defensin 5 expression in intestinal metaplasia of the upper gastrointestinal tract.

B Shen1, E M Porter, E Reynoso, C Shen, D Ghosh, J T Connor, J Drazba, H K Rho, T L Gramlich, R Li, A H Ormsby, M-S Sy, T Ganz, C L Bevins.   

Abstract

BACKGROUND: Upper gastrointestinal tract intestinal metaplasia (IM) is termed Barrett's oesophagus (BO) or gastric intestinal metaplasia (GIM), depending on its location. BO and GIM are associated with chemical exposure resulting from gastro-oesophageal reflux and chronic Helicobacter pylori infection, respectively. Paneth cells (PCs), characterised by cytoplasmic eosinophilic granules, are found in a subset of IM at these sites, but histology may not accurately detect them. AIM: To determine human defensin 5 (HD5; an antimicrobial peptide produced by PCs) expression in BO and GIM, and to investigate its association with H pylori infection.
METHODS: Endoscopic biopsies from 33 patients with BO and 51 with GIM, and control tissues, were examined by routine histology and for H pylori infection and HD5 mRNA and protein expression.
RESULTS: In normal tissues, HD5 expression was specific for PCs in the small intestine. Five patients with BE and 42 with GIM expressed HD5, but few HD5 expressing cells in IM had the characteristic histological features of PCs. Most HD5 positive specimens were H pylori infected and most HD5 negative specimens were not infected.
CONCLUSIONS: HD5 immunohistochemistry was often positive in IM when PCs were absent by conventional histology. Thus, HD5 immunohistochemistry may be superior to histology for identifying metaplastic PCs and distinguishing GIM from BO. The higher frequency of HD5 expression in GIM than in BO is associated with a higher frequency of H pylori infection, suggesting that in IM PCs may form part of the mucosal antibacterial response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976333      PMCID: PMC1770712          DOI: 10.1136/jcp.2004.022426

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  51 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

2.  Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.

Authors:  C L Wilson; A J Ouellette; D P Satchell; T Ayabe; Y S López-Boado; J L Stratman; S J Hultgren; L M Matrisian; W C Parks
Journal:  Science       Date:  1999-10-01       Impact factor: 47.728

3.  Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin.

Authors:  Nita H Salzman; Dipankar Ghosh; Kenneth M Huttner; Yvonne Paterson; Charles L Bevins
Journal:  Nature       Date:  2003-03-19       Impact factor: 49.962

Review 4.  Barrett's esophagus.

Authors:  Gary W Falk
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

5.  Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.

Authors:  Bo Shen; Adrian H Ormsby; Chen Shen; John A Dumot; Yun-Wei Shao; Charles L Bevins; Terry L Gramlich
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

6.  Paneth cell trypsin is the processing enzyme for human defensin-5.

Authors:  Dipankar Ghosh; Edith Porter; Bo Shen; Sarah K Lee; Dennis Wilk; Judith Drazba; Satya P Yadav; John W Crabb; Tomas Ganz; Charles L Bevins
Journal:  Nat Immunol       Date:  2002-05-20       Impact factor: 25.606

7.  Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status.

Authors:  J Wehkamp; K Schmidt; K R Herrlinger; S Baxmann; S Behling; C Wohlschläger; A C Feller; E F Stange; K Fellermann
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

8.  Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis.

Authors:  M Bajaj-Elliott; P Fedeli; G V Smith; P Domizio; L Maher; R S Ali; A G Quinn; M J G Farthing
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2.

Authors:  Cheryl J Hertz; Qi Wu; Edith Martin Porter; Yan J Zhang; Karl-Heinz Weismüller; Paul J Godowski; Tomas Ganz; Scott H Randell; Robert L Modlin
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

10.  Host anti-microbial response to Helicobacter pylori infection.

Authors:  John T George; Parjeet K Boughan; Haris Karageorgiou; Mona Bajaj-Elliott
Journal:  Mol Immunol       Date:  2003-11       Impact factor: 4.407

View more
  18 in total

1.  Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitis.

Authors:  Jivianne T Lee; Mike Jansen; Abebayehu N Yilma; Angels Nguyen; Robert Desharnais; Edith Porter
Journal:  Am J Rhinol Allergy       Date:  2010 Mar-Apr       Impact factor: 2.467

Review 2.  Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis.

Authors:  Charles L Bevins; Nita H Salzman
Journal:  Nat Rev Microbiol       Date:  2011-03-22       Impact factor: 60.633

Review 3.  Inflammatory bowel disease: an impaired barrier disease.

Authors:  Simon Jäger; Eduard F Stange; Jan Wehkamp
Journal:  Langenbecks Arch Surg       Date:  2012-11-18       Impact factor: 3.445

Review 4.  My approach to reporting a gastric biopsy.

Authors:  Carlos A Rubio
Journal:  J Clin Pathol       Date:  2006-09-08       Impact factor: 3.411

Review 5.  Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances.

Authors:  José Luis Llorente; Fernando López; Carlos Suárez; Mario A Hermsen
Journal:  Nat Rev Clin Oncol       Date:  2014-06-17       Impact factor: 66.675

6.  The high affinity IgE receptor Fc epsilonRI is expressed by human intestinal epithelial cells.

Authors:  Eva Untersmayr; Giovanna Bises; Philipp Starkl; Charles L Bevins; Otto Scheiner; George Boltz-Nitulescu; Fritz Wrba; Erika Jensen-Jarolim
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

7.  Antimicrobial peptides in gastrointestinal inflammation.

Authors:  Simon Jäger; Eduard F Stange; Jan Wehkamp
Journal:  Int J Inflam       Date:  2010-11-25

8.  Reduced mucosal antimicrobial activity in Crohn's disease of the colon.

Authors:  Sabine Nuding; Klaus Fellermann; Jan Wehkamp; Eduard F Stange
Journal:  Gut       Date:  2007-04-24       Impact factor: 23.059

9.  Paneth cells in the developing gut: when do they arise and when are they immune competent?

Authors:  Fardou H Heida; Gaia Beyduz; Marian L C Bulthuis; Elisabeth M W Kooi; Arend F Bos; Albertus Timmer; Jan B F Hulscher
Journal:  Pediatr Res       Date:  2016-04-06       Impact factor: 3.756

10.  Alteration in human defensin-5 expression following gastric bypass surgery.

Authors:  M Sundbom; D A Elphick; Y R Mahida; R N Cunliffe; T Midtvedt; L Engstrand; C Rubio; L Göran Axelsson
Journal:  J Clin Pathol       Date:  2007-04-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.